A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Formulations
A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Formulations
Not yet recruiting · NCT07863635 · Registry updated 2026-10-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Formulations | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Not yet recruiting | Phase 4 | 2026-10-07 | NCT07863635 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| ModernaTX, Inc. | 41 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Delricht Research @ Concierge and Direct Primary Care | Overland Park | United States | 2 |
| Delricht Research @ Derby City Direct Primary Care | Louisville | United States | 1 |
| Delricht Research @ Magnolia Family Medicine | Hendersonville | United States | 1 |
| Delricht Research @ Olabisi Badmus | Charlotte | United States | 1 |
| Delricht Research @ Zomnir Family Medicine | Prosper | United States | 2 |